Durvalumab and Tremelimumab and Best Supportive Care vs Best Supportive Care in Patients With Advanced Colorectal Cancer
Clinical trial NCT02870920 · COMPLETED
Trial details
- NCT number
- NCT02870920
- Sponsor
- Canadian Cancer Trials Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-12
- Primary completion
- 2018-10-18
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.